Cimzia 2X200 MG/ML syringe kits
Ended Awarded
- Contract number
- SPE2DB25FLFZ6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,927
Award facts
- Contract value 100% obligated
- $17,927.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,927.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits, with an ultimate completion date of August 8, 2025. This non-set-aside award was issued on August 7, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CIMZIA (certolizumab pegol) is a TNF inhibitor used to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and psoriasis, representing a specialty pharmaceutical product within the company's broader medical supply portfolio.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill complex federal medical supply requirements through competitive procurement processes, with this particular delivery order representing a routine replenishment of specialty pharmaceutical inventory for military healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FLFZ6?
SPE2DB25FLFZ6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FLFZ6 worth?
The government has obligated $17,927 on SPE2DB25FLFZ6.
Is contract SPE2DB25FLFZ6 an order under another contract?
Yes. SPE2DB25FLFZ6 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLFZ6 competed?
The extent of competition for SPE2DB25FLFZ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award